Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Peripheral arterial disease (PAD) is a silent but deadly condition affecting over 316 million people worldwide, yet it frequently goes undiagnosed until it's too late. German vascular surgeons are sounding the alarm, calling for targeted screening and early intervention for at-risk groups. A simple ankle-brachial index test could catch the disease before it leads to amputation or death.
Peripheral arterial disease (PAD) — a condition where leg arteries become dangerously narrowed — affects an estimated 316.54 million people globally, yet it routinely goes undiagnosed until it reaches advanced, life-threatening stages. German vascular surgery leaders are pushing back, calling for urgent awareness, targeted screening, and earlier preventive care for at-risk individuals.
The disease develops silently over years, with key risk factors including smoking, hypertension, lipid disorders, and diabetes (which alone affects ~540 million people worldwide). Once PAD progresses, the consequences are severe: up to 90% of patients may die, face amputation, or develop a new malignancy within 5 years of their first hospital treatment. Encouragingly, a recent analysis found that diagnosing PAD before a first hospitalization leads to better outcomes and fewer complications.
By the Numbers:
Why it matters: PAD is vastly underdiagnosed, and the window for low-cost, high-impact intervention — like ABI testing and supervised walking therapy — is being missed. Earlier detection could spare millions from devastating outcomes while reducing healthcare system costs.
